| Bioactivity | (Rac)-Shikonin (Shikonin) possesses anti-tumor activity. (Rac)-Shikonin (Shikonin) circumvents cancer drug resistance by induction of a necroptotic death[1][2]. |
| Invitro | Shikonin shows a similar potency toward drug-sensitive cancer cell lines (MCF-7 and HEK293) and their drug-resistant lines overexpressing P-glycoprotein, Bcl-2, or Bcl-xL, which account for most of the clinical cancer drug resistance[2]. |
| Name | (Rac)-Shikonin |
| CAS | 54952-43-1 |
| Formula | C16H16O5 |
| Molar Mass | 288.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
(Rac)-Shikonin
CAS: 54952-43-1 F: C16H16O5 W: 288.30
(Rac)-Shikonin (Shikonin) possesses anti-tumor activity. (Rac)-Shikonin (Shikonin) circumvents cancer drug resistance by
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.